Aurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs

Aurobindo Pharma, along with its subsidiary Eugia Pharma Specialities has announced a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market Nilotinib ... Read More